Mark George to Drug Resistance
This is a "connection" page, showing publications Mark George has written about Drug Resistance.
Connection Strength
0.466
-
Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7.
Score: 0.122
-
Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009 Jan; 34(2):522-34.
Score: 0.074
-
Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next? Curr Psychiatry Rep. 2006 Dec; 8(6):445-51.
Score: 0.066
-
Transcranial magnetic stimulation: a stimulating new method for treating depression, but saddled with the same old problems. Int J Neuropsychopharmacol. 2006 Dec; 9(6):637-40.
Score: 0.066
-
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 2005 Sep 01; 58(5):364-73.
Score: 0.060
-
Toward an Evidence-Based, Operational Definition of Treatment-Resistant Depression: When Enough Is Enough. JAMA Psychiatry. 2017 01 01; 74(1):9-10.
Score: 0.033
-
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology. 2006 Jul; 31(7):1345-55.
Score: 0.016
-
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54.
Score: 0.015
-
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005 Sep 01; 58(5):355-63.
Score: 0.015